InSitu Biologics
Oakdale, US · Founded 2017 · Delaware corporation
Find your way into InSitu Biologics
Sign up to see every warm intro you have to InSitu Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the InSitu Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DH
Daniel HalpernExecutive
SK
Sandi KlemannExecutive
JK
James KnappNamed on SEC filing
JS
Jim SegermarkNamed on SEC filing
Board
RW
Robert WilsonBoard director
GV
Greg Van GuilderBoard director
IS
Ivan ShawBoard director
Reported raises · per SEC filings
Form D private placements$13.2M disclosed across 4 of 6 rounds · 2017–2026
▶$1.3MraisedOct 2026 · 1 investors · BiotechnologyRule 506(b)
▶$1.3MraisedOct 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel HalpernExecutive Officer, Director
- Bill TaylorExecutive Officer
- Sandi KlemannExecutive Officer
- Robert WilsonDirector
- Greg Van GuilderDirector
- Ivan ShawDirector
- Offering amount
- $3.4M
- Amount sold
- $1.3M
- Minimum investment
- $2.5M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedDec 2025 · 29 investors · BiotechnologyRule 506(b)
▶$4MraisedDec 2025 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bill TaylorExecutive Officer
- Robert WilsonDirector
- Greg Van GuilderDirector
- Daniel HalpernExecutive Officer, Director
- Sandi KlemannExecutive Officer
- Ivan ShawDirector
- Offering amount
- $8M
- Amount sold
- $4M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedDec 2023 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert WilsonDirector
- James KnappDirector
- Kevin BassettExecutive Officer, Director
- Buzz BensonDirector
- Mark ErethExecutive Officer
- Kay WarnottExecutive Officer
- Kevin BarrettExecutive Officer
- Andy LaFrenceDirector
- Bill TaylorExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $3M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedFeb 2021 · 22 investors · BiotechnologyRule 506(c)
▶$5MraisedFeb 2021 · 22 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Kevin BassettExecutive Officer, Director
- Bill TaylorExecutive Officer
- Kay WarnottExecutive Officer
- Kevin BarrettExecutive Officer
- James KnappDirector
- Robert WilsonDirector
- Andy LaFrenceDirector
- Buzz BensonDirector
- Offering amount
- $5.5M
- Amount sold
- $5M
- Minimum investment
- $50K
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
▶$1MofferedMar 2018 · PharmaceuticalsRule 506(c)
▶$1MofferedMar 2018 · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- James KnappExecutive Officer
- Jim SegermarkExecutive Officer
- Offering amount
- $1M
- Minimum investment
- $50K
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
▶$1MofferedNov 2017 · PharmaceuticalsRule 506(c)
▶$1MofferedNov 2017 · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Jim SegermarkExecutive Officer
- James KnappExecutive Officer
- Offering amount
- $1M
- Minimum investment
- $50K
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has InSitu Biologics raised?
- InSitu Biologics has disclosed $13.2M raised across 4 of its 6 known rounds.
- Where is InSitu Biologics headquartered?
- InSitu Biologics is headquartered in Oakdale, US.